Edmond de Rothschild Holding’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6K | Hold |
315
| – | – | ﹤0.01% | 525 |
|
|
2025
Q1 | $10K | Hold |
315
| – | – | ﹤0.01% | 535 |
|
|
2024
Q4 | $12.2K | Hold |
315
| – | – | ﹤0.01% | 565 |
|
|
2024
Q3 | $14.2K | Hold |
315
| – | – | ﹤0.01% | 591 |
|
|
2024
Q2 | $13.2K | Hold |
315
| – | – | ﹤0.01% | 627 |
|
|
2024
Q1 | $14.3K | Hold |
315
| – | – | ﹤0.01% | 620 |
|
|
2023
Q4 | $14.6K | Hold |
315
| – | – | ﹤0.01% | 630 |
|
|
2023
Q3 | $12.8K | Hold |
315
| – | – | ﹤0.01% | 641 |
|
|
2023
Q2 | $15.3K | Hold |
315
| – | – | ﹤0.01% | 653 |
|
|
2023
Q1 | $15.5K | Hold |
315
| – | – | ﹤0.01% | 663 |
|
|
2022
Q4 | $15.9K | Hold |
315
| – | – | ﹤0.01% | 726 |
|
|
2022
Q3 | $16K | Hold |
315
| – | – | ﹤0.01% | 748 |
|
|
2022
Q2 | $15K | Hold |
315
| – | – | ﹤0.01% | 742 |
|
|
2022
Q1 | $19K | Hold |
315
| – | – | ﹤0.01% | 745 |
|
|
2021
Q4 | $25K | Sell |
315
-1,750
| -85% | -$139K | ﹤0.01% | 764 |
|
|
2021
Q3 | $183K | Buy |
2,065
+315
| +18% | +$27.9K | ﹤0.01% | 551 |
|
|
2021
Q2 | $174K | Buy |
1,750
+387
| +28% | +$38.5K | ﹤0.01% | 546 |
|
|
2021
Q1 | $123K | Buy |
+1,363
| New | +$123K | ﹤0.01% | 541 |
|